Julie Kim is president of the U.S. Business Unit, U.S. country head and member of Takeda’s Executive Team. The U.S. Business Unit portfolio encompasses gastroenterology, neuroscience, plasma-derived therapies and rare diseases.

6 days ago · OSAKA, Japan and CAMBRIDGE, Massachusetts, January 30, 2025 – Takeda (TSE:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor to Christophe Weber, Takeda’s president, chief executive officer (CEO) and …

6 days ago · About Julie Kim Julie Kim has been the president of the U.S. Business Unit and U.S. country head since 2022, and a member of the Takeda Executive Team since 2019. With three decades of experience in health care, Mrs. Kim has held leadership positions at global, regional, country and functional levels.

5 days ago · OSAKA, Japan & CAMBRIDGE, Mass., January 30, 2025--Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, currently president ...

5 days ago · Takeda has named Julie Kim its next CEO, replacing Christophe Weber who will step down in June of 2026 after leading the Japanese company for 11 years. Takeda has named Julie Kim as its next CEO ...

6 days ago · Takeda (TOKYO:4502/NYSE:TAK) announced today that itsBoard of Directors made the decision unanimously to appoint Julie Kim, currently president of Takeda’s U.S. Business Unit, as the successor ...

Julie Kim is President of the U.S. Business Unit, U.S. Country Head and member of Takeda’s Executive Team. The U.S. Business Unit portfolio encompasses gastroenterology, neuroscience, plasma-derived therapies and rare diseases.

5 days ago · Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

ジュリー・キムは、タケダのU.S.ビジネスユニットのプレジデントおよびU.S.カントリーヘッドです。2019年のシャイアー社の買収によりタケダに入社しました。

5 days ago · Julie Kim is set to replace Christophe Weber as the new CEO of Takeda Pharmaceutical, becoming the first woman to lead the more than 240-year-old Japanese drugmaker. Kim, 54, has been running ...